EANO Meeting - Sunday, September 27, 2026
Note that the programme is subject to change and will be continuously updated.
All times are in Central European Summer Time (CEST).
08:00-09:00
Michael Platten, Germany
President EANO
09:00-10:30
Chairs: TBC, TBC
JS07.1 Imaging biomarkers of neurocognition: how to integrate imaging in treatment planning
Laurien de Roeck, Belgium
JS07.2 Mechanisms of Radiotherapy-induced neurotoxicity
Rifaquat Rahman, United States
JS07.3 How to assess the tumor growth and response to treatments (including imaging biomarkers neurocognitive damage)
TBC, -
JS07.4 Radiotherapy and systemic agent combination in preclinical models and clinical settings
TBC, -
Chairs: Maximilian Mair, TBC
JS08.1 Molecular basics of PET imaging in neuro-oncology
Nelleke Tolboom, Netherlands
JS08.2 PET imaging in clinical practice: experience and guidelines
Norbert Galldiks, Germany
JS08.3 The emerging role of PET imaging for clinical trials
Nathalie Albert, Germany
JS08.4 Current status and future directions of theranostics in neuro-oncology
Matthias Preusser, Austria
Chairs: TBC, TBC
OS12.1 Individualized interventions for neuropsychological problems in pediatric brain tumors
Marita Partanen, Netherlands
OS12.2 Interventions for improving neurocognitive functioning in paediatric brain tumour survivors
TBC, -
OS12.3 Latest symptom management insights in adults with brain tumours: spotlight on epilepsy management
Edward Avila, United States
OS12.4 The role of rehabilitation in optimising quality of survival
Anna Zanotto, United States
10:30-11:00 Coffee break
11:00-12:30
Chairs: TBC, TBC
JS09.1 Cancer Neuroscience
Richard Drexler, United States
JS09.2 Oncolytic virotherapy for glioblastoma
Eva Galanis, United States
JS09.3 DNA damage response inhibitors for the treatment of glioblastoma
Anthony Chalmers, United Kingdom
JS09.4 (Personalized) vaccination for glioblastoma
Katharina Sahm, Germany
Chairs: TBC, TBC
OS13.1 Injectable bioresorbable conductive hydrogels as active post-resection therapeutic platforms
TBC, -
OS13.2 Technical considerations and next-generation application of interstitial fluid and longitudinal CSF monitoring
Terry Burns, United States
OS13.3 Brain injury biomarkers to quantify neurobiological cost of tumor treatment
Thomas Skoglund, Sweden
OS13.4 Human CNS Tissue Effects in 5-ALA Sonodynamic Therapy
Shwetal Mehta, United States
Chairs: TBC, TBC
JS10.1 Advanced MRI Techniques in glioma follow-up: when and how?
Albert Pons-Escoda, Spain
JS10.2 Chemical Exchange Saturation Transfer
TBC, -
JS10.3 Magnetic Resonance Spectroscopy for molecular diagnosis and follow-up in glioma
TBC, -
JS10.4 Pioneering pre-clinical MR imaging of glioma
TBC, -
12:30-12:45
Michael Platten, Germany
EANO President
Giuseppe Minniti, Italy
President EANO Meeting 2026